We believe people should have access to
effective medical innovations
when they need them,
no matter where they live.
-
Our impact
Since 2017, MedAccess-supported products have…
reached
539m
people
-
Our impact
Since 2017, MedAccess-supported products have…
reached
>110
low- and middle-income countries
-
Our impact
Since 2017, MedAccess-supported products have…
saved
$108m
for procurers, making more products available at lower prices
Access to health products is unequal
We believe people should have access to effective medical innovations when they need them, no matter where they live.
But for millions of people in low- and middle-income countries, these innovations are either unavailable or unaffordable.
We partner with makers and buyers
We broker partnerships to remove barriers stopping lifesaving medical innovations reaching people who need them.
Our agreements speed up access, shouldering financial risk to create a viable market.
Shaping markets and generating impact
We select medical innovations that tackle unmet needs and measure our impact by products distributed and people reached.
We do things differently, interrogating the reasons behind market failures and pursuing solutions through finance and expertise.
Learn more about MedAccess
Our 2023 Annual Review explores progress on our innovative finance agreements, key milestones reached across the year, and our latest impact data.
Learn more about how our market shaping work is accelerating access to healthcare products.
Latest news
Find out more about our partnerships by reading our press releases, news stories and insight articles.
Latest news
28 October 2024 | News
The role of forecasting in market shaping: Hema Srinivasan on Forecasting Impact podcast
24 September 2024 | News
MedAccess joins G7 DFIs initiative to prepare for future pandemics
17 July 2024 | Insight
